Compare Crowdstrike Holdings Inc (CRWD) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crowdstrike Holdings Inc vs Tenet Healthcare Corporation — how do they compare? Crowdstrike Holdings Inc trades at $267.1 (market cap $269.31B), while Tenet Healthcare Corporation trades at $260 (market cap $20.98B). The key difference: Crowdstrike Holdings Inc is far larger — about 12.8× Tenet Healthcare Corporation's market cap, and Crowdstrike Holdings Inc is trading nearer its 52-week high, Tenet Healthcare Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Crowdstrike Holdings Inc for 97 Days and Tenet Healthcare Corporation for 15 Days on average.
| CRWD | THC | |
|---|---|---|
Market Cap | $269.31B | $20.98B |
Volume | 9,381,560 | 428,008 |
Sector | Technology | Health |
52-Week High | $278.86 | $280.77 |
52-Week Low | $87.56 | $161.37 |
Typical Hold Time | 97 Days | 15 Days |
Enterprise Value | $265.11B | $32.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CrowdStrike (CRWD) trades at $265.44, down 4.81% today but remains near its 52-week high. The stock shows strong technical momentum with bullish moving averages and has consistently beaten earnings expectations. Revenue growth remains robust at $3.95 billion for 2025, though profitability is challenged with a net loss of $19.27 million. Analyst sentiment is overwhelmingly positive with 76% buy ratings and a $235.74 consensus price target, while recent news highlights AI-driven cybersecurity opportunities.
CrowdStrike presents a growth-focused opportunity with strong revenue expansion and market leadership in AI-native cybersecurity. However, elevated valuation multiples and inconsistent profitability create risk. The stock's proximity to all-time highs suggests near-term consolidation potential, but long-term prospects remain favorable given cybersecurity demand trends and AI integration.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with a bullish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (ROE 53.31%, net margin 9.9%). Recent news highlights strong cash flow supporting capital returns and upcoming Q3 2026 results on October 29. Valuation appears reasonable with P/E of 10.07 and EV/EBITDA of 5.75.
THC presents a compelling investment case with strong analyst support (81% buy ratings) and 7% upside to consensus target of $283.36. Key catalysts include sustained earnings momentum and efficient capital allocation. Risks include surgical volume pressures and cash flow sustainability concerns amid aggressive buybacks. The stock's current technical setup near pivot point $259 suggests balanced risk-reward.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crowdstrike Holdings Inc
CrowdStrike Holdings provides cybersecurity products and services aimed at protecting organizations from cyberthreats. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, identity protection, and log management. CrowdStrike went public in 2019 and serves customers worldwide.
Read more on CRWD →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
